Sanofi’s Alpha-1 Antitrypsin Deficiency (AATD) Thought Leader Liaison (TLL) is a field-based commercial role that: (1) leverages data to seamlessly identify and profile customers, (2) coordinates HCP peer-to-peer and patient programming, as well as (3) gathers insights across customer groups to inform commercial strategy and execution. The TLL is expected to possess a high level of knowledge regarding the AATD landscape and compliance to be successful in engaging customers, while adhering to all pharma, field, and headquarters protocols and procedures when engaging customers. The TLL engages key opinion leaders (KOLs) on the AATD speaker bureau to provide education to HCPs and patients, the latter of which is enabled by patient advocacy groups (PAGs). This role closely collaborates with internal customer-facing teams to ensure a One Sanofi approach, as well as with HQ teams, working within approved SOPs. The TLL directly reports through the US HQ Commercial organization to the AATD TLL Head, and succeeds through exceptional strategic planning, communication, collaboration, and flawless execution. At launch, Sanofi expects this role to transition into an HCP-facing Sales role, including transitioning to quarterly incentive compensation eligibility.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level